Skip to main content
SpringerLink
Log in

Complex therapies for advanced Parkinson’s disease: what is the role of doctor-patient communication?

  • Original Article
  • Published:
Neurological Sciences Aims and scope Submit manuscript

Abstract

Objectives

Communication processes play a key role in the patient-doctor relationship. Few studies have considered communicative processes in advanced Parkinson’s disease (PD), and in particular in the phase of proposing complex therapies (CT). Therefore, we explored the role of communication and patient-doctor relationship in the transition phase to CT for advanced PD, analysing satisfaction, factors influencing the relationship and patients’ unmet needs.

Materials and methods

Twenty-four PD patients (mean age 61.7 ± 8.8 years; mean disease duration 12 ± 4.8 years) eligible for deep brain stimulation or infusion therapies were submitted to a semi-structured interview aimed to investigate communication-related cognitions, feelings and behaviours concerning PD and the possible transition towards CT. The Patient-Doctor Relationship Questionnaire (PDRQ-9) was administered along with neuropsychological and behavioural screening tests.

Results

All patients discussed the possible transition to CT with a neurologist. A high degree of satisfaction about the relationship with the neurologist was revealed (mean PDRQ-9 score 37.3 ± 7.3). The communication not only aroused feelings of fear (11/24 patients) and concern (15/24 patients), but also fostered the hope for motor improvement (15/24 patients). Half the patients (12/24) wanted to receive more information about CT after communication.

Conclusions

This pilot study highlights the importance of doctor-patient communication in PD when facing the transition to CT. Trust in the physician emerged as a key point in favour of the therapeutic alliance. Neurologists should carefully consider patients’ reactions and preferences for eliciting collaboration and treatment adherence, favouring a patient-centred standard of care.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Travaline JM, Ruchinskas R, D’Alonzo GE (2005) Patient-Physician Communication: Why and How. JAOA Clinical Practice 105(1):13–18

    Google Scholar 

  2. Poewe W, Mahlknecht P (2009) The clinical progression of Parkinson’s disease. Parkinsonism Relat Disord 15(Suppl 4):S28–S32. https://doi.org/10.1016/S1353-8020(09)70831-4

    Article  PubMed  Google Scholar 

  3. Macleod AD, Counsell CE (2016) Predictors of functional dependency in Parkinson's disease. Mov Disord 31(10):1482–1488. https://doi.org/10.1002/mds.26751

    Article  PubMed  PubMed Central  Google Scholar 

  4. Prakasha KM, Nadkarnid NV, Lyed WK, Yonga MH, Tana EK (2016) The impact of non-motor symptoms on the quality of life of Parkinson’s disease patients: a longitudinal study. Eur J Neurol 23(5):854–860. https://doi.org/10.1111/ene.12950

    Article  Google Scholar 

  5. Krack P, Batir A, Van Blercom N et al (2003) Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson’s disease. N Engl J Med 349(20):1925–1934

    Article  CAS  Google Scholar 

  6. Olanow CW, Kieburtz K, Odin P et al (2014) Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson’s disease: a randomised, controlled, doubleblind, double-dummy study. Lancet Neurol 13(2):141–149. https://doi.org/10.1016/S1474-4422(13)70293-X

    Article  CAS  PubMed  Google Scholar 

  7. Katzenschlager R, Poewe W, Rascol O, Trenkwalder C, Deuschl G, Chaudhuri KR, Henriksen T, van Laar T, Spivey K, Vel S, Staines H, Lees A (2018) Apomorphine subcutaneous infusion in patients with Parkinson's disease with persistent motor fluctuations (TOLEDO): a multicentre, double-blind, randomised, placebo-controlled trial. Lancet Neurol 17(9):749–759. https://doi.org/10.1016/S1474-4422(18)30239-4

    Article  CAS  PubMed  Google Scholar 

  8. Fahn S, Oakes D, Shoulson I, Kieburtz K, Rudolph A, Lang A et al (2004) Levodopa and the progression of Parkinson’s disease. N Engl J Med 351(24):2498–2508

    Article  CAS  Google Scholar 

  9. Fox SH, Katzenschlager R, Lim SY, Ravina B, Seppi K, Coelho M (2011) The Movement Disorder Society evidence-based medicine review update: treatments for the motor symptoms of Parkinson’s disease. Mov Disord 26(Suppl 3):S2–S41. https://doi.org/10.1002/mds.23829

    Article  Google Scholar 

  10. Morgan JC, Fox SH (2016) Treating the Motor Symptoms of Parkinson Disease. Continuum (Minneap Minn) 22(4 Movement Disorders):1064–1085. https://doi.org/10.1212/CON.0000000000000355

    Article  Google Scholar 

  11. Coelho M, Ferreira JJ (2012) Late-stage Parkinson disease. Nat Rev Neurol 8(8):435–442. https://doi.org/10.1038/nrneurol.2012.126

    Article  CAS  PubMed  Google Scholar 

  12. Ossig C, Reichmann H (2013) Treatment of Parkinson’s disease in the advanced stage. J Neural Transm 120(4):523–529. https://doi.org/10.1007/s00702-013-1008-y

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Krüger R, Hilker R, Winkler C, Lorrain M, Hahne M, Redecker C (2016) Advanced stages of PD: interventional therapies and related patient-centered care. J Neural Transm 123(1):31–43. https://doi.org/10.1007/s00702-015-1418-0

    Article  PubMed  Google Scholar 

  14. Weaver FM, Follett K, Stern M, Hur K, Harris C, Marks WJ (2009) Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease: a randomized controlled trial. JAMA 301(1):63–73. https://doi.org/10.1001/jama.2008.929

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Xie CL, Shao B, Chen J, Zhou Y, Lin SY (2016) Effects of neurostimulation for advanced Parkinson's disease patients on motor symptoms: A multiple-treatments meta-analysis of randomized controlled trials. Sci Rep 6:25285. https://doi.org/10.1038/srep25285

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Wirdefelt K, Odin P, Nyholm D (2016) Levodopa–Carbidopa Intestinal Gel in Patients with Parkinson’s Disease: A Systematic Review. CNS Drugs 30(5):381–404. https://doi.org/10.1007/s40263-016-0336-5

    Article  CAS  Google Scholar 

  17. Hamberg K, Hariz G (2014) The decision-making process leading to deep brain stimulation in men and women with Parkinson’s disease – an interview study. BMC Neurol 14:89. https://doi.org/10.1186/1471-2377-14-89

    Article  PubMed  PubMed Central  Google Scholar 

  18. Lökk J (2011) Lack of information and access to advanced treatment for Parkinson’s disease patients. J Multidiscip Healthc 4:433–439. https://doi.org/10.2147/JMDH.S27180

    Article  PubMed  PubMed Central  Google Scholar 

  19. Hughes AJ, Ben-Shlomo Y, Daniel SE, Lees AJ (1992) What features improve the accuracy of clinical diagnosis in Parkinson's disease: a clinicopathologic study. Neurology 42(6):1142–1146

    Article  CAS  Google Scholar 

  20. Emre M, Aarsland D, Brown R, Burn DJ, Duyckaerts C, Mizuno Y, Broe GA, Cummings J, Dickson DW, Gauthier S, Goldman J, Goetz C, Korczyn A, Lees A, Levy R, Litvan I, McKeith I, Olanow W, Poewe W, Quinn N, Sampaio C, Tolosa E, Dubois B (2007) Clinical diagnostic criteria for dementia associated with Parkinson's disease. Mov Disord 22(12):1689–1707

    Article  Google Scholar 

  21. American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders, 5th edn. Arlington, VA

    Book  Google Scholar 

  22. Fallowfield L, Jenkins V (2004) Communicating sad, bad, and difficult news in medicine. Lancet 363(9405):312–319

    Article  Google Scholar 

  23. Baile WF, Buckman R, Lenzi R, Glober G, Beale EA, Andrzej AP (2000) SPIKES-A Six-Step Protocol for Delivering Bad News: Application to the Patient with Cancer. Oncologist 5(4):302–311

    Article  CAS  Google Scholar 

  24. Van der Feltz-Cornelis CM, Van Oppen P, Van Marwijk HWJ, De Beurs E, Van Dick R (2004) A patient-doctor relationship questionnaire (PDRQ-9) in primary care: development and psychometric evaluation. Gen Hosp Psychiatry 26(2):115–120

    Article  Google Scholar 

  25. Folstein MF, Folstein SE, McHugh PR (1975) “Mini-Mental State”: A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12(3):189–198

    Article  CAS  Google Scholar 

  26. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561–571

    Article  CAS  Google Scholar 

  27. Spielberger CD, Gorsuch RL, Lushene PR, Vagg PR, Jacobs GA (1983) Manual for the State-Trait Anxiety Inventory. Consulting Psychologists Press, Palo Alto

    Google Scholar 

  28. Tashakkori A, Teddlie C (2003) Handbook of Mixed Methods in Social & Behavioral Research. Sage, Thousand Oaks

    Google Scholar 

  29. Creswell JW, Plano Clark VL (2011) Designing and conducting mixed methods research. Sage, Thousand Oaks

    Google Scholar 

  30. Lincoln YS, Guba EG (1985) Naturalistic Inquiry. Sage Publications Ltd, London

    Book  Google Scholar 

  31. Mayring P (2000) Qualitative content analysis. Forum Qual Soc Res

  32. Wilkinson D, Birmingham P (2003) Using Research Instruments: A guide for researchers. Routledge, Falmer

    Google Scholar 

  33. Kim M, Yun JY, Jeon B, Lim YH, Kim K, Yang H et al (2016) Patients' reluctance to undergo deep brain stimulation for Parkinson's disease. Parkinsonism Relat Disord 23:91–94. https://doi.org/10.1016/j.parkreldis.2015.11.010

    Article  PubMed  Google Scholar 

  34. Abbruzzese G, Barone P, Bonuccelli U, Lopiano L, Antonini A (2012) Continuous intestinal infusion of levodopa/carbidopa in advanced Parkinson’s disease: efficacy, safety and patient selection. Funct Neurol 27(3):147–154

    PubMed  Google Scholar 

  35. Frith CD, Frith U (2011) Mechanisms of social cognition. Annu Rev Psychol 63:287–313. https://doi.org/10.1146/annurev-psych-120710-100449

    Article  PubMed  Google Scholar 

  36. Korkmaz B (2011) Theory of mind and neurodevelopmental disorders of childhood. Pediatr Res 69(5 Pt 2):101R–108R. https://doi.org/10.1203/PDR.0b013e318212c177

    Article  PubMed  Google Scholar 

  37. Sabbagh MA (2004) Understanding orbitofrontal contributions to theory-of-mind reasoning: implications for autism. Brain Cogn 55(1):209–219

    Article  Google Scholar 

  38. Back A, Arnold RM, Tulsky JA (2009) Mastering Communication with Seriously Ill Patients: Balancing Honesty with Empathy and Hope. Cambridge University Press, New York

    Book  Google Scholar 

  39. Nijhuis FA, van Heek J, Bloem BR, Post B, Faber MJ (2016) Choosing an Advanced Therapy in Parkinson's Disease; is it an Evidence-Based Decision in Current Practice? J Park Dis 6(3):533–543. https://doi.org/10.3233/JPD-160816

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neuroscience “Rita Levi Montalcini”, University of Torino, Via Cherasco 15, 10126, Turin, Italy

    Elisa Montanaro, Carlo Alberto Artusi, Maurizio Zibetti & Leonardo Lopiano

Authors
  1. Elisa Montanaro
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Carlo Alberto Artusi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Maurizio Zibetti
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Leonardo Lopiano
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Elisa Montanaro.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical standards

This study has been approved by the local ethical committee and performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Montanaro, E., Artusi, C.A., Zibetti, M. et al. Complex therapies for advanced Parkinson’s disease: what is the role of doctor-patient communication?. Neurol Sci 40, 2357–2364 (2019). https://doi.org/10.1007/s10072-019-03982-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-019-03982-5

Keywords

Search

Navigation